COPT Defense Properties (NYSE:CDP – Get Free Report) released its quarterly earnings data on Monday. The company reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.34), FiscalAI reports. The business had revenue of $200.64 million during the quarter, compared to analyst estimates of $185.10 million. COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.65 earnings per share. COPT Defense Properties updated its FY 2026 guidance to 2.730-2.790 EPS and its Q2 2026 guidance to 0.680-0.700 EPS.
COPT Defense Properties Trading Down 0.8%
Shares of CDP stock opened at $31.00 on Friday. COPT Defense Properties has a fifty-two week low of $25.99 and a fifty-two week high of $33.29. The company has a 50 day moving average price of $31.82 and a 200 day moving average price of $30.30. The stock has a market capitalization of $3.51 billion, a P/E ratio of 22.46 and a beta of 0.80. The company has a debt-to-equity ratio of 1.63, a quick ratio of 3.95 and a current ratio of 2.85.
COPT Defense Properties Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 4.1%. This is an increase from COPT Defense Properties’s previous quarterly dividend of $0.30. The ex-dividend date was Tuesday, March 31st. COPT Defense Properties’s dividend payout ratio (DPR) is presently 92.75%.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on CDP
Insider Transactions at COPT Defense Properties
In other COPT Defense Properties news, Director Philip L. Hawkins sold 5,536 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $32.71, for a total transaction of $181,082.56. Following the sale, the director directly owned 15,188 shares in the company, valued at $496,799.48. This represents a 26.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.66% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On COPT Defense Properties
Several hedge funds and other institutional investors have recently made changes to their positions in CDP. Invesco Ltd. increased its stake in shares of COPT Defense Properties by 1.3% during the fourth quarter. Invesco Ltd. now owns 768,242 shares of the company’s stock worth $21,357,000 after buying an additional 10,221 shares during the period. Mercer Global Advisors Inc. ADV lifted its stake in COPT Defense Properties by 47.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 10,723 shares of the company’s stock worth $298,000 after acquiring an additional 3,439 shares during the last quarter. State of Tennessee Department of Treasury lifted its stake in COPT Defense Properties by 7.7% in the fourth quarter. State of Tennessee Department of Treasury now owns 370,872 shares of the company’s stock worth $11,427,000 after acquiring an additional 26,453 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in COPT Defense Properties during the 4th quarter worth approximately $234,000. Finally, Wellington Management Group LLP grew its holdings in COPT Defense Properties by 135.7% during the 4th quarter. Wellington Management Group LLP now owns 865,165 shares of the company’s stock worth $24,052,000 after acquiring an additional 498,175 shares in the last quarter.
About COPT Defense Properties
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
Recommended Stories
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
